Psoriasis: open trials in Austria

4 open trials have a site in Austria. Registry data; only the trial team decides who can take part.

NCT06846541
An Extension Study to Evaluate Safety, Efficacy, and Durability of Response to ESK-001 for Moderate to Severe Plaque Psoriasis (ONWARD3)
Trial Treatment · Phase 3 · Alumis Inc.
Klinik Hietzing, Vienna
Registry updated 2026-09-16
NCT06764693
An Ex-US Study to Assess Treatment Persistence With Risankizumab in Adult Participants With Psoriatic Arthritis
Research · AbbVie
Krankenhaus Der Barmherzigen Brueder Graz /ID# 273764, Graz · Medizinische Universitaet Graz /ID# 273765, Graz · Landesklinikum Stockerau /ID# 275618, Stockerau · Rheuma-Zentrum Wien-Oberlaa GmbH /ID# 275617, Vienna
Registry updated 2026-02-17
NCT06029257
A Study of Tildrakizumab in the Treatment of Genital Psoriasis (CZATCH-Genital-PsO)
Research · Almirall, S.A.
Medizinische Universität Graz, Graz
Registry updated 2025-01-29
NCT06030076
A Study to Assess the Effects of Switching From a Biologic Treatment to Tildrakizumab Using Patient-reported Outcomes in Adult Participants With Moderate to Severe Plaque Psoriasis
Research · Almirall, S.A.
Gesundheitszentrum Citypark Graz, Graz
Registry updated 2025-01-29

This page is not medical advice. Talk to your doctor before contacting a trial.

An Extension Study to Evaluate Safety, Efficacy, and Durability of Response to ESK-001 for Moderate to Severe Plaque Psoriasis (ONWARD3)